ES2135355B1 - Vacuna anti-vibrio anguillarum (gava-3) para la prevencion de la enfermedad vibriosis del rodaballo y peces salmonidos, y procedimiento de obtencion. - Google Patents

Vacuna anti-vibrio anguillarum (gava-3) para la prevencion de la enfermedad vibriosis del rodaballo y peces salmonidos, y procedimiento de obtencion.

Info

Publication number
ES2135355B1
ES2135355B1 ES009800889A ES9800889A ES2135355B1 ES 2135355 B1 ES2135355 B1 ES 2135355B1 ES 009800889 A ES009800889 A ES 009800889A ES 9800889 A ES9800889 A ES 9800889A ES 2135355 B1 ES2135355 B1 ES 2135355B1
Authority
ES
Spain
Prior art keywords
procedure
vibrio anguillarum
vibriosis
vaccine
cect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES009800889A
Other languages
English (en)
Other versions
ES2135355A1 (es
Inventor
Rodriguez Ysabel Santos
Toranzo Alicia Estevez
Perez Juan Luis Barja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidade de Santiago de Compostela
Original Assignee
Universidade de Santiago de Compostela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidade de Santiago de Compostela filed Critical Universidade de Santiago de Compostela
Priority to ES009800889A priority Critical patent/ES2135355B1/es
Priority to CA002294618A priority patent/CA2294618A1/en
Priority to EP99911820A priority patent/EP1001016A1/en
Priority to PCT/ES1999/000089 priority patent/WO1999055835A1/es
Publication of ES2135355A1 publication Critical patent/ES2135355A1/es
Priority to NO996428A priority patent/NO996428D0/no
Application granted granted Critical
Publication of ES2135355B1 publication Critical patent/ES2135355B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/63—Vibrio

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Procedimiento de obtención de la vacuna GAVA-3 anti-Vibrio anguillarum para la prevención de la enfermedad vibriosis producida por la bacteria Vibrio anguillarum en rodaballo y peces salmónidos cultivados en agua de mar. El procedimiento se caracteriza por incluir en la vacuna las células bacterianas y los productos extracelulares inactivados con formol de tres cepas de Vibrio anguillarum pertenecientes a los serotipos O1 y O2, (subgrupos O2{al y O2{be ) (Cepas depositadasen la Colección Española de Cultivos Tipo, CECT, con los números de accesión CECT 5031, CECT 5032 y CECT 5033). La vacuna puede ser administrada por baño corto, baño prolongado opor inyección y confiere al rodaballo y peces salmónidos niveles notables de protección frente a la vibriosis.
ES009800889A 1998-04-27 1998-04-27 Vacuna anti-vibrio anguillarum (gava-3) para la prevencion de la enfermedad vibriosis del rodaballo y peces salmonidos, y procedimiento de obtencion. Expired - Fee Related ES2135355B1 (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ES009800889A ES2135355B1 (es) 1998-04-27 1998-04-27 Vacuna anti-vibrio anguillarum (gava-3) para la prevencion de la enfermedad vibriosis del rodaballo y peces salmonidos, y procedimiento de obtencion.
CA002294618A CA2294618A1 (en) 1998-04-27 1999-04-06 Anti-vibrio anguillarum vaccine (gava-3) for the prevention of the vibriosis disease in the turbot and salmonidae, and preparation process
EP99911820A EP1001016A1 (en) 1998-04-27 1999-04-06 ANTI-$i(VIBRIO ANGUILLARUM) VACCINE (GAVA-3) FOR THE PREVENTION OF THE VIBRIOSIS DISEASE IN THE TURBOT AND SALMONIDAE, AND PREPARATION PROCESS
PCT/ES1999/000089 WO1999055835A1 (es) 1998-04-27 1999-04-06 Vacuna anti-vibrio anguillarum (gava-3) para la prevencion de la enfermedad vibriosis en rodaballo y peces salmonidos, y procedimiento de obtencion
NO996428A NO996428D0 (no) 1998-04-27 1999-12-23 Anti-Vibrio anguillarum-vaksine (GAVA-3) for forhindring av vibriosen i piggvar og laksefisk og fremgangsmåten for fremstilling av slike vaksiner

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009800889A ES2135355B1 (es) 1998-04-27 1998-04-27 Vacuna anti-vibrio anguillarum (gava-3) para la prevencion de la enfermedad vibriosis del rodaballo y peces salmonidos, y procedimiento de obtencion.

Publications (2)

Publication Number Publication Date
ES2135355A1 ES2135355A1 (es) 1999-10-16
ES2135355B1 true ES2135355B1 (es) 2000-07-01

Family

ID=8303604

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009800889A Expired - Fee Related ES2135355B1 (es) 1998-04-27 1998-04-27 Vacuna anti-vibrio anguillarum (gava-3) para la prevencion de la enfermedad vibriosis del rodaballo y peces salmonidos, y procedimiento de obtencion.

Country Status (5)

Country Link
EP (1) EP1001016A1 (es)
CA (1) CA2294618A1 (es)
ES (1) ES2135355B1 (es)
NO (1) NO996428D0 (es)
WO (1) WO1999055835A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007128348A1 (en) * 2006-05-09 2007-11-15 Inve Technologies Nv Compositions comprising lytic enzymes of bacteriophages for treating bacterial infections
CN103275890A (zh) * 2013-05-03 2013-09-04 中国水产科学研究院黄海水产研究所 一株鳗弧菌（鳗利斯顿氏菌）强毒菌株及其应用
CN104138597B (zh) * 2013-05-07 2016-09-14 中国水产科学研究院黄海水产研究所 一种鳗弧菌二价疫苗及其制备和使用方法
CN110241057A (zh) * 2019-07-23 2019-09-17 福建九为生物技术有限公司 一种直投式蛭弧菌发酵剂及其制备方法和使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862313A (en) * 1974-01-17 1975-01-21 Us Interior Vibrio vaccine and immunization
JPS5423118A (en) * 1977-07-25 1979-02-21 Kitasato Inst Vaccine for bibrio disease of bred fish
JPS5699423A (en) * 1980-09-10 1981-08-10 Kitasato Inst:The Immune endowment to cultured fish by vaccine of vibrio disease

Also Published As

Publication number Publication date
CA2294618A1 (en) 1999-11-04
EP1001016A1 (en) 2000-05-17
NO996428L (no) 1999-12-23
WO1999055835A1 (es) 1999-11-04
NO996428D0 (no) 1999-12-23
ES2135355A1 (es) 1999-10-16

Similar Documents

Publication Publication Date Title
Chen et al. Screening vaccine candidate strains against Streptococcus agalactiae of tilapia based on PFGE genotype
AR047067A1 (es) Metodos para el uso de bifidobacterias probioticas para animales de compania
EP2849780B1 (en) Fish vaccine
EP3071226B1 (en) Fish vaccine
CA1335663C (en) Fish vaccine
CA2391203A1 (en) Cross-protective salmonella vaccines containing an avirulent salmonella choleraesuis strain
US9913888B2 (en) Fish vaccine
ES2135355B1 (es) Vacuna anti-vibrio anguillarum (gava-3) para la prevencion de la enfermedad vibriosis del rodaballo y peces salmonidos, y procedimiento de obtencion.
Austin et al. Recovery of Serratia plymuthica and presumptive Pseudomonas pseudoalcaligenes from skin lesions in rainbow trout, Oncorhynchus mykiss (Walbaum), otherwise infected with enteric redmouth.
Thakur et al. Pathogenicity and antibiotic susceptibility of Vibrio species isolated from moribund shrimps
McNulty et al. Streptococcus iniae infection and tissue distribution in hybrid striped bass (Morone chrysops× Morone saxatilis) following inoculation of the gills
CN107753578A (zh) 一种快速杀灭口腔病毒的复合益生菌抑菌液
Austin et al. Pseudomonads
Kanchanopas-Barnette et al. The first isolation of Photobacterium damselae subsp. damselae from Asian seabass Lates calcarifer
CN110075289A (zh) 一种副猪嗜血杆菌、猪链球菌与胸膜肺炎放线杆菌三联灭活疫苗及其应用
Majumdar et al. An attenuated plasmid-cured strain of Aeromonas hydrophila elicits protective immunity in Clarias batrachus L.
Laurencin et al. Some results of vaccination against vibriosis in Brittany
ES2139549B1 (es) Vacuna anti-flexibacter maritimus (fm-95) para la prevencion de la enfermedad "flexibacteriosis marina" en rodaballo y peces salmonidos, y procedimiento de obtencion.
Nayak et al. Original Research Article Characterization, pathogenicity, antibiotic sensitivity and immune response of Flavobacterium columnare isolated from Cirrhinus mrigala and Carassius auratus
Romalde et al. Long-lasting protection against turbot streptococcosis obtained with a toxoid-enriched bacterin
CN110124022A (zh) 一种猪肺炎支原体与副猪嗜血杆菌、猪链球菌、胸膜肺炎放线杆菌四联灭活疫苗及其应用
ES2115551B1 (es) Vacuna anti-enterococus sp (et-2) para la prevencion de la enfermedad enterococus del rodaballo y procedimiento de obtencion.
JEREMIC et al. WITH YERS/NIA RUCKERI BACTERIN
Austin et al. Flavobacteria and cytophagas
Ananthan et al. Biochemical characteristics & secretory activity of Aeromonas species isolated from children with gastroenteritis in Chennai

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19991016

Kind code of ref document: A1

Effective date: 19991016

FD2A Announcement of lapse in spain

Effective date: 20180803